Abbott Laboratories - Total Other Finance Cost

Abbott Laboratories's Fiscal Year is From January To December - All Figures are in USD, Millions.

The item "Total-Other-Finance-Cost" stands at 26.00 Million United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025, the highest value since 09/30/2023.

Abbott Laboratories's third quarter result of 77.00 Million USD for the item "Total Other Finance Cost" represents an increase of 340.62 percent compared to it's second quarter result.

Also, Abbott Laboratories's third quarter result of 77.00 Million USD for the item "Total Other Finance Cost" represents an increase of 420.83 percent compared to it's third quarter result of last year.

Looking again at the trailing twelve months series (TTM), Abbott Laboratories's third quarter result of 26.00 Million USD for the item "Total Other Finance Cost" represents an increase of 134.67 percent compared to it's second quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 130.00 Million United States Dollars compared to the value the year prior.
The 1 year change is 130.00 Million United States Dollars.
The 3 year change is -422.00 Million United States Dollars.
The 5 year change is -38.00 Million United States Dollars.
The 10 year change is 191.00 Million United States Dollars.

The Serie's long term average value is -177.53 Million United States Dollars. It's latest available value, on 09/30/2025, is 203.53 Million United States Dollars higher, compared to it's long term average value.
The Serie's change in United States Dollars from it's minimum value, on 12/31/2017, to it's latest available value, on 09/30/2025, is +880.00 Million.
The Serie's change in United States Dollars from it's maximum value, on 12/31/2021, to it's latest available value, on 09/30/2025, is -545.00 Million.